STOCK TITAN

Arcosa, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Arcosa, Inc. (NYSE: ACA) will release Q4 and full year 2023 results on Feb 22, 2024, followed by an earnings call on Feb 23, 2024. The call details and webcast link are provided for access. A recording and replay will be available for a limited time.
Positive
  • None.
Negative
  • None.

DALLAS--(BUSINESS WIRE)-- Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the fourth quarter and full year ended December 31, 2023 after markets close on Thursday, February 22, 2024.

The Company will host an earnings call to discuss the results at 8:30 a.m. Eastern Time on Friday, February 23, 2024. The call can be accessed as follows:

Webcast and slide presentation:

https://ir.arcosa.com

The slides will be available for download in advance of the call

 

Dial in:

Domestic 800-343-1703

International 785-424-1116

Conference ID ARCOSA

Passcode 75986

A recording of the conference call will be available through 11:59 p.m. Eastern Time on March 8, 2024 by dialing 800-839-8798 for domestic callers and 402-220-6078 for international callers. A replay will also be available for one year on the Company’s website at https://ir.arcosa.com/news-events/events-presentations.

About Arcosa

Arcosa, Inc., headquartered in Dallas, Texas, is a provider of infrastructure-related products and solutions with leading positions in construction, engineered structures, and transportation markets. Arcosa reports its financial results in three principal business segments: Construction Products, Engineered Structures, and Transportation Products. For more information, visit www.arcosa.com.

INVESTOR CONTACTS

Gail M. Peck

Chief Financial Officer

Erin Drabek

Director of Investor Relations

T 972.942.6500

InvestorResources@arcosa.com

David Gold

ADVISIRY Partners

T 212.661.2220

David.Gold@advisiry.com

MEDIA CONTACT

Media@arcosa.com

Source: Arcosa, Inc.

FAQ

When will Arcosa release its Q4 and full year 2023 results?

Arcosa will release its Q4 and full year 2023 results on February 22, 2024.

When is the earnings call to discuss the results?

The earnings call to discuss the results will be on February 23, 2024 at 8:30 a.m. Eastern Time.

How can the earnings call be accessed?

The earnings call can be accessed through webcast and slide presentation at https://ir.arcosa.com, or by dialing the provided phone numbers.

How long will the recording of the conference call be available?

The recording of the conference call will be available through 11:59 p.m. Eastern Time on March 8, 2024.

Where can the replay of the conference call be accessed?

The replay will be available for one year on the Company’s website at https://ir.arcosa.com/news-events/events-presentations.

Arcosa, Inc.

NYSE:ACA

ACA Rankings

ACA Latest News

ACA Stock Data

4.24B
47.81M
1.21%
92.7%
1%
Water and Sewer Line and Related Structures Construction
Construction
Link
United States of America
DALLAS

About ACA

arcosa, inc. is a provider of infrastructure-related products and solutions with leading brands serving construction, engineered structures, and transportation markets. our individual businesses have built reputations for quality, service, and operational excellence over decades. arcosa serves a broad spectrum of infrastructure-related markets and is strategically focused on driving organic and disciplined acquisition growth to capitalize on the fragmented nature of many of the industries in which we operate. with arcosa’s current platform of businesses and additional growth opportunities, we are well- aligned with key market trends, such as the replacement and growth of aging transportation infrastructure, the continued shift to renewable power generation, and the expansion of new transmission, distribution, and telecommunications infrastructure. our common stock is traded on the new york stock exchange under the symbol aca.